Abstract
AIMS: Imbalances of iron metabolism have been linked to the development of atherosclerosis. However, subjects with hereditary haemochromatosis have a lower prevalence of cardiovascular disease. The aim of our study was to understand the underlying mechanisms by combining data from genome-wide association study analyses in humans, CRISPR/Cas9 genome editing, and loss-of-function studies in mice.
METHODS AND RESULTS: Our analysis of the Global Lipids Genetics Consortium (GLGC) dataset revealed that single nucleotide polymorphisms (SNPs) in the haemochromatosis gene HFE associate with reduced low-density lipoprotein cholesterol (LDL-C) in human plasma. The LDL-C lowering effect could be phenocopied in dyslipidaemic ApoE-/- mice lacking Hfe, which translated into reduced atherosclerosis burden. Mechanistically, we identified HFE as a negative regulator of LDL receptor expression in hepatocytes. Moreover, we uncovered liver-resident Kupffer cells (KCs) as central players in cholesterol homeostasis as they were found to acquire and transfer LDL-derived cholesterol to hepatocytes in an Abca1-dependent fashion, which is controlled by iron availability.
CONCLUSION: Our results disentangle novel regulatory interactions between iron metabolism, KC biology and cholesterol homeostasis which are promising targets for treating dyslipidaemia but also provide a mechanistic explanation for reduced cardiovascular morbidity in subjects with haemochromatosis.
Original language | English |
---|---|
Pages (from-to) | 3949-3959B |
Number of pages | 11 |
Journal | European Heart Journal |
Volume | 41 |
Issue number | 40 |
DOIs | |
Publication status | Published - 21 Oct 2020 |
Keywords
- Animals
- Atherosclerosis/genetics
- Cholesterol, LDL
- Clustered Regularly Interspaced Short Palindromic Repeats
- Genome-Wide Association Study
- Hemochromatosis/genetics
- Hemochromatosis Protein
- Homeostasis
- Humans
- Kupffer Cells
- Mice
- Receptors, LDL